Literature DB >> 16963408

ALS: cytokine profile in cerebrospinal fluid T-cell clones.

Trygve Holmøy1, Per M Roos, Espen Østhagen Kvale.   

Abstract

T -cells are present in the spinal cord from patients with amyotrophic lateral sclerosis (ALS), and could attack neurons or activate microglia through secretion of cytokines. We report that interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, interleukin (IL)-2, IL-4, IL-5 and IL-10 could not be detected in cerebrospinal fluid (CSF) samples from 15 ALS patients and 23 out of 25 controls with a multiplexed cytometric bead assay. In vivo activated T-cell clones were established from CSF (n = 26) and blood (n = 21) of one ALS patient. The proliferative capacity of CSF T-cell clones was lower than that of T-cell clones from blood (p = 0.0007). All CD4+ CSF T-cell clones produced IFN-gamma, compatible with a predominant T helper (h) 1 phenotype, but several T-cell clones also produced Th2 cytokines. These data suggest that in vivo activated intrathecal T-cells can be induced to secrete cytokines which may play a role in ALS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963408     DOI: 10.1080/17482960600664730

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  5 in total

1.  Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India.

Authors:  G Nagesh Babu; Alok Kumar; Ramesh Chandra; S K Puri; Jayantee Kalita; U K Misra
Journal:  Neurochem Res       Date:  2008-02-02       Impact factor: 3.996

Review 2.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

3.  Evaluating the levels of CSF and serum factors in ALS.

Authors:  Jie Guo; Xuan Yang; Lina Gao; Dawei Zang
Journal:  Brain Behav       Date:  2017-02-19       Impact factor: 2.708

4.  Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression.

Authors:  Andrea Malaspina; Natasa Jokic; Wenlong L Huang; John V Priestley
Journal:  BMC Genomics       Date:  2008-10-23       Impact factor: 3.969

5.  Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Paula Korhonen; Eveliina Pollari; Katja M Kanninen; Ekaterina Savchenko; Šárka Lehtonen; Sara Wojciechowski; Yuriy Pomeshchik; Ludo Van Den Bosch; Gundars Goldsteins; Jari Koistinaho; Tarja Malm
Journal:  IBRO Rep       Date:  2019-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.